MSD Partners L.P. 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:30 pm Unchanged | 2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MSD Partners L.P. | 101,010 7.000% | 0 (Unchanged) | Filing |
| 2020-02-14 4:47 pm Purchase | 2019-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MSD Partners L.P. | 101,010 7.300% | 27,768 (+37.91%) | Filing |